BCPEM
Bain Capital Public Equity Management Portfolio holdings
AUM
$1.03B
This Quarter Return
+14.96%
1 Year Return
+30.54%
3 Year Return
+135.1%
5 Year Return
+224.71%
10 Year Return
–
AUM
$3.99B
AUM Growth
+$3.99B
(-6.7%)
Cap. Flow
-$852M
Cap. Flow
% of AUM
-21.38%
Top 10 Holdings %
Top 10 Hldgs %
44.74%
Holding
61
New
18
Increased
5
Reduced
19
Closed
9
Top Buys
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
$149M |
| 2 |
SWI
SOLARWINDS INC COM STK (DE)
SWI
|
$91.6M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
$79.5M |
| 4 |
AMC Networks
AMCX
|
$52.2M |
| 5 |
PTC Therapeutics
PTCT
|
$50.1M |
Top Sells
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
$149M |
| 2 |
Gilead Sciences
GILD
|
$133M |
| 3 |
PPG Industries
PPG
|
$119M |
| 4 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
$88.7M |
| 5 |
EMC
EMC CORPORATION
EMC
|
$80.1M |
Sector Composition
| 1 | Technology | 18.37% |
| 2 | Consumer Staples | 15.36% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Healthcare | 10.75% |
| 5 | Industrials | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
IQVIA
IQV
$31.4B
| $66.1M | 1.66% |
1,472,940
| – | – |
|
|
IDIX
27
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| $65.7M | 1.65% |
12,664,950
| – | – |
|
|
PARA
28
DELISTED
Paramount Global Class B
PARA
| $59.9M | 1.5% |
1,086,611
-546,000
| -33% | -$30.1M |
|
|
PTLA
29
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $58.4M | 1.47% |
2,185,013
| – | – |
|
|
30
AMC Networks
AMCX
$316M
| $52.2M | 1.31% |
+762,400
| New | +$52.2M |
|
|
31
PTC Therapeutics
PTCT
$4.41B
| $50.1M | 1.26% |
+2,333,333
| New | +$50.1M |
|
|
MDVN
32
DELISTED
MEDIVATION, INC.
MDVN
| $49.5M | 1.24% |
1,651,374
-2,602,776
| -61% | -$78M |
|
|
HMIN
33
DELISTED
HOMEINNS HOTEL GROUP SPONSORED ADR
HMIN
| $40.6M | 1.02% |
1,221,604
| – | – |
|
|
RKUS
34
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $39.2M | 0.98% |
2,327,700
-935,300
| -29% | -$15.7M |
|
35
Autodesk
ADSK
$67.9B
| $34.4M | 0.86% |
+836,435
| New | +$34.4M |
|
36
Illumina
ILMN
$15.2B
| $29.6M | 0.74% |
376,343
-862,397
| -70% | -$67.8M |
|
37
Sarepta Therapeutics
SRPT
$1.98B
| $23.6M | 0.59% |
+500,000
| New | +$23.6M |
|
38
Alnylam Pharmaceuticals
ALNY
$58.6B
| $22.4M | 0.56% |
+350,100
| New | +$22.4M |
|
39
Puma Biotechnology
PBYI
$258M
| $17.9M | 0.45% |
332,791
-411,612
| -55% | -$22.1M |
|
|
GEVA
40
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $16.9M | 0.42% |
+266,141
| New | +$16.9M |
|
41
Telefônica Brasil
VIV
$19.7B
| $16.2M | 0.41% |
+721,352
| New | +$16.2M |
|
42
Agios Pharmaceuticals
AGIO
$2.36B
| $14.6M | 0.37% |
+521,800
| New | +$14.6M |
|
43
ICICI Bank
IBN
$113B
| $13M | 0.33% |
+2,338,600
| New | +$13M |
|
|
ALU
44
DELISTED
ALCATEL-LUCENT ADR
ALU
| $9.07M | 0.23% |
2,673,288
-11,671,952
| -81% | -$39.6M |
|
|
RGLS
45
DELISTED
Regulus Therapeutics
RGLS
| $8.49M | 0.21% |
+7,500
| New | +$8.49M |
|
|
BIND
46
DELISTED
BIND THERAPEUTICS INC
BIND
| $6.35M | 0.16% |
+450,000
| New | +$6.35M |
|
|
BCOV
47
DELISTED
Brightcove, Inc.
BCOV
| $5.85M | 0.15% |
520,006
| – | – |
|
48
Fortress Biotech
FBIO
$87.8M
| $5.43M | 0.14% |
+51,667
| New | +$5.43M |
|
49
Cognizant
CTSH
$35.1B
| $5.06M | 0.13% |
+123,134
| New | +$5.06M |
|
|
CYNI
50
DELISTED
CYAN INC COM
CYNI
| $3.52M | 0.09% |
350,000
| – | – |
|